[Regeneron Pharmaceuticals](https://www.regeneron.com/about)

Rolling

Not specified; funding level and duration determined per project and proposal.

Supports independent investigators and clinicians in research initiatives aligned with Regeneron's scientific and medical interests, ensuring regulatory and ethical compliance.

--- ## Description This mechanism provides support for independent investigators and clinicians seeking to conduct research projects or collaborations that align with Regeneron’s scientific and medical priorities. The program is designed to facilitate investigator-initiated studies and research partnerships, while maintaining strict compliance with legal, regulatory, and ethical standards. All activities must adhere to institutional requirements and industry codes, and any collaborative relationship with Regeneron must remain transparent and compliant. --- ## Due Dates - Applications are accepted on a rolling basis; there are no specified submission deadlines or cycles. --- ## Funding Amount - No specific funding ranges, caps, or durations are published. - Funding level, term, and eligible costs are determined through the application and review process based on the nature of the proposed research. --- ## Eligibility - Eligible applicants: - Independent third-party investigators - Clinicians - Eligible activities: - Investigator-initiated studies - Research collaborations - All applicants must: - Ensure research is designed and conducted in accordance with regulatory, ethical, and institutional standards - Comply with Regeneron policies and all relevant laws and industry codes - No specific institutional or geographic restrictions are listed, but applicants should confirm alignment with Regeneron's areas of interest. --- ## Application Process - Applications must be submitted through the [dedicated third-party research requests portal](https://regenerontpr.versaic.com/login). - Applicants must register for an account on the portal. - The portal will provide detailed submission instructions, including: - Required documentation (protocols, budgets, justifications, approvals) - Steps for uploading materials and managing your proposal - No information is provided on the need for a letter of intent, specific forms, or review timelines. - Applicants are encouraged to consult the portal for the most current requirements and guidance. --- ## Additional Information - All research activities must comply with: - FDA regulations and guidance - OIG guidance - Federal and state laws and regulations - Regeneron’s compliance standards and policies - Industry codes (e.g., PhRMA) as relevant - Financial relationships and research support must be transparently disclosed and managed according to applicable ethical standards. --- ## External Links - [Regeneron Pharmaceuticals – Grants & Funding Overview](https://www.regeneron.com/about/grants#corporate-funding-application) - [Third-party research requests portal (application submission)](https://regenerontpr.versaic.com/login) - [Corporate Funding Application Portal (general)](https://regeneron.versaic.com/) - [Regeneron Privacy Notice](https://www.regeneron.com/privacy-notice) - [Contact Regeneron](https://www.regeneron.com/contact-us) --- ## Contact Information | Type | Details | |--------------|------------------------------------------------------------------------| | General Info | [Regeneron Contact Page](https://www.regeneron.com/contact-us) | | Technical Help (portal) | [Portal FAQ/Help](https://regeneron.versaic.com/faq) |

Third-party research requests

Sign in to see full grant listing